Friday, December 14, 2012
Roche wins EU nod for breast cancer drug Perjeta
Roche wins EU nod for breast cancer drug Perjeta: ZURICH (Reuters) - European health regulators recommended Roche's breast cancer drug Perjeta for approval on Friday, cementing the company's hopes that the drug will become the standard of care for an aggressive, incurable form of cancer.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment